Antiretroviral could prevent HIV

• May 4, 2024

According to some specialists, he assures that the antiretroviral called Truvada can be used as a preventive medicine in the fight against HIV , a condition that is diagnosed to 50 thousand people every year, in the United States.

The panel of counselors points out that Truvada can be prescribed to those who are part of a risk group, including homosexual men and couples in which one of the two is HIV positive, to reduce the risk of contagion.

However, some doctors consider that the use of this antiretroviral would trigger sexual risk behaviors, in people who feel protected with the medication; while other specialists point out that the discovery represents a big step in the treatment against HIV .

In the next video, the doctor Anthony Fauci , of the National Institute of Allergies and Infectious Diseases explains the importance of the discovery and to which sectors of the population it would benefit:

The power of antiretroviral

Truvada, which is produced by the pharmaceutical company Gilead Sciences, combines two antiretroviral drugs that were used in the past separately (tenofovir / emtricitabine) in HIV-positive patients.

In clinical trials of antiretrovirals, published in the New England Journal of Medicine , show that taking it daily reduces the risk of transmission of HIV up to 73%.

In information published by the BBC It is stressed that the antiretroviral does not replace the condoms or to other methods of protection, so all persons with an active sexual life are recommended to take all necessary precautions.

The specialists assure that if the Food and Drug Administration (FDA) of the United States, approves the recommendation, it would be the first time that a antiretroviral It is used in healthy individuals for the prevention of infection , which affects 3.7 million people in the world every year. It is expected that the US authorities will give their final decision on June 15.

"Arial", "sans-serif" ">

Video Medicine: Developing Antiretroviral Therapy in Africa (DART Clinical Trial) -- Policy Recommendations (May 2024).